Aprinoia Therapeutics Company
Biotechnology, Neuorscience
Total Funding:
57530000.0
Headquarters:
Boston, Massachusetts, United States
Last Funding Date:
2021-12-28
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Investors Number:
8.0
Industry:
Neuroimaging
Funding Status:
Late Stage Venture
Founded Date:
2015-05-20